Orexins and the treatment of obesity

European Journal of Pharmacology

Volumn 440, Issue 2-3, 2002, Pages 199-212

  Smart, Darren ^a,b   Haynes, Andrea C ^a   Williams, Gareth ^b   Arch, Jonathan R S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b University Hospital Aintree ^*  (United Kingdom)

Author keywords

Feeding; Hypocretin; Narcolepsy; Orexin; SB 334867; Sleep wake cycle

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1 (2 METHYLBENZOXAZOL 6 YL) 3 [1,5]NAPHTHYRIDIN 4 YLUREA; 4 [(4 AMINO QUINAZOLIN 2 YLAMINO)METHYL]CYCLOHEXYLMETHYLAMIDE; AMINO ACID; CGP 71683 A; G PROTEIN COUPLED RECEPTOR; GR 231118; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; OREXIN A; OREXIN B; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ARTICLE; FEEDING; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; MAMMAL; NONHUMAN; OBESITY; PRECURSOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY;

ANIMALS; BENZOXAZOLES; BODY WEIGHT; CARRIER PROTEINS; EATING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; UREA;

EID: 0037066586     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01429-2     Document Type: Article

References (135)

1. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice
2. The role of orexins in the regulation of feeding: A perspective
3. Orexins and obesity
4. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma
5. Immunoreactive orexin-A in human plasma
6. Alteration of the expression of the hypocretin (orexin) gene by 2-deoxyglucose in the rat lateral hypothalamic area
7. Hypothalamic hypocretin/orexin and neuropeptide Y: Divergent interaction with energy depletion and leptin
8. Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus
9. Orexin-A, an hypothalamic peptide with analgesic properties
10. Hypothalamic orexin-A-immunopositive neurons express Fos in response to central glucopenia
11. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems
12. Orexin-A excites serotonergic neurons in the dorsal raphe nucleus of the rat
13. Hypothalamic orexin expression: Modulation by blood glucose and feeding
14. Down-regulation of orexin gene expression by severe obesity in the rats: Studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone
15. Food restriction selectively increases hypothalamic orexin-B levels in lactating rats
16. Hypoglycemia activates orexin neurons and selectively increases hypothlamic orexin-B levels
17. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
18. Orexin A-like immunoreactivity in the rat brain
19. Immunohistochemical distribution of orexin-A and orexin-B-containing neurones and fibres in the rat brain and spinal cord
20. Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor
21. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
22. Distribution of orexin/hypocretin in the rat median eminence and pituitary
23. Effect of the anti-obesity agent sibutramine in obese-diabetic ob/ob mice
24. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
25. Neuropeptide Y and energy balance: One way ahead for the treatment of obesity?
26. Hyperphagia induced by hypoglycemia in rats is independent of leptin and hypothalamic neuropeptide Y
27. Evidence of neuropeptide Y Y5 receptor involvement in food intake elicited by orexin A in sated rats
28. Orexins: A role in medullary sympathetic outflow
29. 2C receptor involvement
30. Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs
31. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin
32. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
33. Changes in CSF hypocretin-1 (orexin-A) levels in rats across 24 hours and in response to food deprivation
34. Morphological evidence for neural interactions between leptin and orexin in the hypothalamus
35. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frog Rana ridibunda
36. Effect of peripheral 2-DG on opioid and neuropeptide Y gene expression
37. Opioids and food intake: Distributed functional neural pathways
38. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats
39. Insulin-induced hypoglycemia increases preprohhypocretin (orexin) mRNA in the rat lateral hypothalamic area
40. Orexigenic innervation of POMC-containing neurones in the rat arcuate nucleus
41. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
42. Leptin receptor and STAT-3 immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus
43. Separate systems for serotonin and leptin in appetite control
44. Behavioural Satiety Sequence (BSS) for the diagnosis of drug action on food intake
45. Genetic ablation of orexin neurones in mice results in narcolepsy, hypophagia and obesity
46. Effects of single and chronic ICV administration of the orexins on feeding in the rat
47. Interaction of the orexins and melanin concentrating hormone on feeding
48. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats
49. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice
50. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord
51. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides
52. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations
53. Induction of outward current by orexin-B in mouse peritoneal macrophages
54. Effects of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioural activities of rats
55. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats
56. Transgenic approach to the study of body weight regulation
57. Evidence that Neuropeptide Y Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats
58. The orexins: Pharmacology and physiology
59. Effects of centrally administered orexin-B and orexin-A: A role for orexin-1 receptors in orexin-B-induced hyperactivity
60. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
61. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin
62. Nicotine up-regulates expression of orexin and its receptors in rat brain
63. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion
64. The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
65. Orexin synthesis and response in the gut
66. Orexin-A and leptin change inversely in fasting non-obese subjects
67. Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B
68. Orexin expression in lateral hypothalamic neurons is stimulated by a high-fat diet and is elevated in normal-weight rats prone to obesity on a high-fat diet
69. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
70. Leptin receptor, neuropeptide Y, POMC mRNA expression in the diet-induced obese mouse brain
71. Orexin A preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro
72. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus
73. A fall in blood glucose level precedes meal onset in free-feeding rats
74. Differential distribution and regulation of orexin-1 and orexin-2 orexin/hypocretin receptor messenger RNA in the brain upon fasting
75. Independent feeding and metabolic actions of orexins in mice
76. 2+ influx pathway necessary for coupling to phospholipase C
77. Differential expression of orexin receptors 1 and 2 in the rat brain
78. Orexin-A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade
79. Hypocretin deficiency in familial symptomatic narcolepsy
80. Radioimmunoassay for orexin A
81. Widespread distribution or orexin in rat brain and its regulation upon fasting
82. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia
83. Hypocretin 1 in the lateral hypothalamus activates key feeding-regulatory brain sites
84. Distribution of orexin neurons in the adult rat brain
85. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system
86. Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells
87. Neuropeptide Y in central control of feeding and interactions with orexin and leptin
88. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by orexin-1 receptor activation
89. Neurons containing hypocretin (orexin) project to multiple neuronal systems
90. Orexin A activates leptin-responsive neurons in the arcuate nucleus
91. Influence of topiramate in the regulation of energy balance
92. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats
93. SB-334867, a selective orexin-1 receptor antagonist enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats
94. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight
95. Orexins and orexin receptors: Implication in feeding behaviour
96. Orexins and orexin receptors - A family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behaviour
97. Melanin-concentrating hormone (MCH) antagonizes the effects of α-MSH and peptide E-I on grooming and locomotor activities in the rat
98. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of neuropeptide Y, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus
99. Structure, tissue distribution, and pharmacological characterisation of Xenopus orexins
100. Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons
101. Sympathetic and cardiovascular actions of orexins in conscious rats
102. Viewpoint: Are studies in genetically altered mice out of control?
103. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals
104. Orexins: A new family of neuropeptides
105. Characterisation of recombinant human orexin receptor pharmacology in a Chinese Hamster Ovary cell-line using FLIPR
106. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors
107. SB-334867-A: The first selective orexin-1 receptor antagonist
108. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity
109. Effect of central injections of anti-orexin 1 receptor antibody on food intake in rats
110. On the synthesis of orexin-A: A novel one-step procedure to obtain peptides with two intramolecular disulphide bonds
111. Neuropeptide Y chronically injected into the hypothalamus: A powerful neuro-chemical inducer of hyperphagia and obesity
112. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats
113. Orexins: Effects on behaviour and localisation of orexin receptor 2 messenger ribonulceic acid in the rat brainstem
114. The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding
115. Feeding response to central orexins
116. Orexins/hypocretins: Waking up the scientific world
117. Distribution and quantification of immunoreactive orexin A in rat tissues
118. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system
119. Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats
120. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus
121. Distribution of orexin receptor mRNA in the rat brain
122. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord
123. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin
124. Lateral hypothalamus: Early developmental expression and response to hypocretin (orexin)
125. Modulation of the promoter region of prepro-hypocretin by α-interferon
126. Synergistic interaction between CCK and leptin to regulate food intake
127. Orexin in the regulation of feeding and wakefulness
128. Food intake and the regulation of body weight
129. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats
130. Down regulation of the prepro-orexin gene expression in genetically obese mice
131. Postnatal development of orexin/hypocretin in rats
132. Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice
133. Chronic intracerebroventricular administration or orexin-A to rats increases food intake in daytime, but has no effect on body weight
134. Orexin-induced food intake involves neuropeptide pathway
135. Orexin-A regulates body temperature in coordination with arousal status